Existing Customer

Renew your plan
Refer & Earn
HomeGreater Than Icon
Gujarat Themis Biosyn LtdGreater Than Icon
Gujarat Themis Biosyn Ltd Financials
Company Logo

Gujarat Themis Biosyn Ltd Financial Statement

Gujarat Themis Biosyn Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue39.35
Operating Expense20.28
Net Profit13.24
Net Profit Margin33.65
Earning Per Share1.82
EBIDTA19.03
Effective Tax Rate23.96

Gujarat Themis Biosyn Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual169.82
Operating Expenses Annual91.09
Operating Profit Annual83.10
Interest Annual0.23
Depreciation4.06
Net Profit Annual59.16
Tax Annual20.17

Gujarat Themis Biosyn Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning6.06
Cash Flow from Operations64.21
Cash Flow from Investing-55.21
Cash Flow from Financing-8.59
Cash Flow at the End6.47

Gujarat Themis Biosyn Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)48.93
PBIT Margin (%)46.85
PBT Margin (%)-156.84
Net PROFIT Margin (%)34.84
Return On Networth / Equity (%)33.76
Return On Networth /Employed (%)44.82
Return On Assets (%)33.44
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)0.96

Gujarat Themis Biosyn Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual38.02
Total Current Assets Annual47.56
Non Current Assets Annual173.55
Total Shareholders Funds Annual201.38
Total Assets Annual221.11

Gujarat Themis Biosyn Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Jul 27, 2024, Gujarat Themis Biosyn Ltd has a market capitalization of 2,877.41 Cr. Value Research classifies it as a Mid-Cap company.
Yes, Gujarat Themis Biosyn Ltd is debt-free with a debt-to-equity ratio of 0.01.
In FY 2023 , Gujarat Themis Biosyn Ltd recorded a total revenue of approximately 169.82 Cr marking a significant milestone in the company's financial performance.
Gujarat Themis Biosyn Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.8% and 0.2% annually, respectively..
Gujarat Themis Biosyn Ltd's current PE ratio is 48.64.
Gujarat Themis Biosyn Ltd's ROCE averaged 49.4% from the FY ending March 2022 to 2024, with a median of 51.9%. It peaked at 57.3% in March 2022, reflecting strong capital efficiency over the period..
Gujarat Themis Biosyn Ltd's latest EBIT is Rs. 79.56 Cr, surpassing the average EBIT of Rs. 72.35 Cr over the 5 years..